Abbott Laboratories buy Oppenheimer Holdings Inc.
Start price
23.01.26
/
50%
€92.26
Target price
23.01.27
€112.37
Performance (%)
-10.82%
Price
17.04.26
€82.28
Summary
This prediction is currently active. The prediction for Abbott Laboratories disappoints with a performance of -10.82%. This prediction currently runs until 23.01.27. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -3.766% | -3.766% |
| iShares Core DAX® | 3,59 % | 3,93 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % |
| iShares S&P 500 | 4,14 % | 4,04 % |
Comments by Oppenheimer_Holdings for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE:ABT) had its price target lowered by analysts at Oppenheimer Holdings, Inc. from $140.00 to $132.00. They now have an "outperform" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Oppenheimer_Holdings for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€80.40
17.04.26
17.04.26
€97.66
17.04.27
17.04.27
2.34%
17.04.26
17.04.26
Abbott Laboratories
Start price
Target price
Perf. (%)
€103.98
08.10.24
08.10.24
€118.42
08.10.25
08.10.25
10.58%
09.10.25
09.10.25